COVID-19 information
Diabetes studies have been paused to allow clinical staff to focus on managing COVID-19 patients.
Diabetes patients are at an increased risk of COVID-19 complications and the Research team has undertaken large scale data-based projects on diabetes and COVID-19 with findings reported in many publications. Several other studies on the impact of COVID-19 on diabetes are also planned.
University Hospitals Birmingham NHS Foundation Trust (UHB) has been at the forefront of diabetes research for over 30 years and is one of the leading diabetes research units globally.
Based at Heartlands Hospital and Queen Elizabeth Hospital Birmingham, the Diabetes Research team includes accomplished academics, clinicians and research nurses.
The team has a broad portfolio and has led on a number of key research projects that include:
- the genetics of type 1 diabetes
- the epidemiology of type 2 diabetes, looking particularly at ethnicity (UK Asian Diabetes Study)
- new therapies for type 1 and type 2 diabetes
Our open trials focus on a number of topics:
- Preventing type 1 diabetes
- Exercise and type 1 diabetes
- Type 2 Diabetes in Youth
- Sleep apnoea and type 2 diabetes
- Epidemiology of type 2 diabetes
- Prevention of microvascular diabetes complications
- Non-alcoholic fatty liver disease (NAFLD)
- Diabetic kidney disease (FLOW)
- Obesity and cardiovascular disease (SELECT)
The team’s work has been published in a number of prestigious journals:
- New England Journal of Medicine
- The Lancet
- Diabetes Care
- Diabetologia
- Diabetic Medicine
Common conditions and trial topics
- Type 1 diabetes:
- epidemiology
- prevention
- exercise
- new treatments
- Epidemiology of type 2 diabetes
- Bariatric (obesity) surgery in type 2 diabetes
- Diabetic kidney disease
- Non-alcoholic fatty liver disease (NAFLD)
- Cardiovascular outcomes in type 2 diabetes
- Sleep apnoea and diabetes
- Type 2 diabetes in young people
- Ethnicity and diabetes
Contact information
Last reviewed: 27 April 2021